Conversely, in a different study, TMPRSS2:ERG fusion detected by RNA sequencing in prostate cancer samples was associated with a lower lymphocytic infiltration, a finding that could potentially interfere with the biology of the tumor immune response [22]. Here, TMPRSS2 is linked to prostate cancer.